

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 9.39256685 |
| 2 | Fc-gamma receptor signaling pathway (GO:0038094) | 9.39256685 |
| 3 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 9.39256685 |
| 4 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 9.27997894 |
| 5 | retina homeostasis (GO:0001895) | 8.47029723 |
| 6 | humoral immune response (GO:0006959) | 7.85161271 |
| 7 | positive regulation of respiratory burst (GO:0060267) | 6.47420118 |
| 8 | negative regulation of B cell proliferation (GO:0030889) | 6.45368729 |
| 9 | glomerular filtration (GO:0003094) | 6.40606149 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.30186828 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 6.17180675 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.01248297 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.01248297 |
| 14 | negative regulation of glucose import (GO:0046325) | 5.93341066 |
| 15 | renal filtration (GO:0097205) | 5.84947265 |
| 16 | positive regulation of Rho protein signal transduction (GO:0035025) | 5.82677495 |
| 17 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 5.82362121 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 5.69266068 |
| 19 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 5.53493134 |
| 20 | L-fucose metabolic process (GO:0042354) | 5.47935532 |
| 21 | L-fucose catabolic process (GO:0042355) | 5.47935532 |
| 22 | fucose catabolic process (GO:0019317) | 5.47935532 |
| 23 | regulation of B cell differentiation (GO:0045577) | 5.24810346 |
| 24 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 5.14793142 |
| 25 | negative regulation of glucose transport (GO:0010829) | 4.86624935 |
| 26 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.67546410 |
| 27 | regulation of B cell proliferation (GO:0030888) | 4.65145493 |
| 28 | signal peptide processing (GO:0006465) | 4.56944643 |
| 29 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.51058164 |
| 30 | cellular response to zinc ion (GO:0071294) | 4.43748537 |
| 31 | regulation of respiratory burst (GO:0060263) | 4.19575832 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.16340227 |
| 33 | positive regulation of Rap GTPase activity (GO:0032854) | 4.09469155 |
| 34 | antibacterial humoral response (GO:0019731) | 3.95144490 |
| 35 | phenylpropanoid metabolic process (GO:0009698) | 3.92064781 |
| 36 | germinal center formation (GO:0002467) | 3.88837919 |
| 37 | Fc receptor signaling pathway (GO:0038093) | 3.85163249 |
| 38 | antimicrobial humoral response (GO:0019730) | 3.83122981 |
| 39 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.79151007 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75122772 |
| 41 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.75082518 |
| 42 | maternal placenta development (GO:0001893) | 3.74905283 |
| 43 | bone resorption (GO:0045453) | 3.74481182 |
| 44 | immune response-activating signal transduction (GO:0002757) | 3.71613545 |
| 45 | positive regulation of nuclease activity (GO:0032075) | 3.70801814 |
| 46 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.70660960 |
| 47 | immunoglobulin mediated immune response (GO:0016064) | 3.70656624 |
| 48 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.69560572 |
| 49 | negative regulation of osteoclast differentiation (GO:0045671) | 3.68406128 |
| 50 | Fc-epsilon receptor signaling pathway (GO:0038095) | 3.67362269 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64360944 |
| 52 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.63344422 |
| 53 | intestinal epithelial cell development (GO:0060576) | 3.62530228 |
| 54 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.59890553 |
| 55 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.58722208 |
| 56 | peptidyl-asparagine modification (GO:0018196) | 3.55600593 |
| 57 | mature B cell differentiation (GO:0002335) | 3.54998924 |
| 58 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.54351539 |
| 59 | negative regulation of cell killing (GO:0031342) | 3.54283712 |
| 60 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54283712 |
| 61 | regulation of nuclease activity (GO:0032069) | 3.51451111 |
| 62 | regulation of Rap GTPase activity (GO:0032317) | 3.51280312 |
| 63 | surfactant homeostasis (GO:0043129) | 3.49355254 |
| 64 | N-acetylneuraminate metabolic process (GO:0006054) | 3.45481368 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.42636794 |
| 66 | type I interferon signaling pathway (GO:0060337) | 3.42636794 |
| 67 | cellular response to unfolded protein (GO:0034620) | 3.40917693 |
| 68 | response to type I interferon (GO:0034340) | 3.39962201 |
| 69 | mannose metabolic process (GO:0006013) | 3.35981617 |
| 70 | activation of immune response (GO:0002253) | 3.34820721 |
| 71 | detection of other organism (GO:0098543) | 3.33195649 |
| 72 | protein N-linked glycosylation (GO:0006487) | 3.32189968 |
| 73 | detection of bacterium (GO:0016045) | 3.29682001 |
| 74 | sequestering of metal ion (GO:0051238) | 3.25686232 |
| 75 | positive regulation of immunoglobulin production (GO:0002639) | 3.24902194 |
| 76 | negative regulation of B cell activation (GO:0050869) | 3.23596598 |
| 77 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.20623631 |
| 78 | regulation of B cell activation (GO:0050864) | 3.19503731 |
| 79 | B cell proliferation (GO:0042100) | 3.19371881 |
| 80 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18039522 |
| 81 | ER-nucleus signaling pathway (GO:0006984) | 3.16226129 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.13511529 |
| 83 | COPI coating of Golgi vesicle (GO:0048205) | 3.11218963 |
| 84 | Golgi transport vesicle coating (GO:0048200) | 3.11218963 |
| 85 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08712561 |
| 86 | cellular response to topologically incorrect protein (GO:0035967) | 3.07728106 |
| 87 | respiratory burst (GO:0045730) | 3.06990984 |
| 88 | defense response to Gram-negative bacterium (GO:0050829) | 3.05226441 |
| 89 | response to endoplasmic reticulum stress (GO:0034976) | 3.02248954 |
| 90 | complement activation, classical pathway (GO:0006958) | 20.6546599 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93458255 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 2.92567506 |
| 93 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.91892268 |
| 94 | proline biosynthetic process (GO:0006561) | 2.91361294 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 2.89953801 |
| 96 | apoptotic cell clearance (GO:0043277) | 2.87485201 |
| 97 | regulation of cellular extravasation (GO:0002691) | 2.87425536 |
| 98 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85385086 |
| 99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.85106908 |
| 100 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.84945385 |
| 101 | leukocyte aggregation (GO:0070486) | 2.84274127 |
| 102 | flavonoid metabolic process (GO:0009812) | 2.82996462 |
| 103 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.80484043 |
| 104 | B cell homeostasis (GO:0001782) | 2.79580883 |
| 105 | fucose metabolic process (GO:0006004) | 2.79475396 |
| 106 | mature B cell differentiation involved in immune response (GO:0002313) | 2.78753576 |
| 107 | nerve growth factor signaling pathway (GO:0038180) | 2.78732619 |
| 108 | detection of external biotic stimulus (GO:0098581) | 2.78429813 |
| 109 | neutrophil activation (GO:0042119) | 2.77620923 |
| 110 | negative thymic T cell selection (GO:0045060) | 2.77564869 |
| 111 | B cell mediated immunity (GO:0019724) | 2.77129085 |
| 112 | serine transport (GO:0032329) | 2.73509274 |
| 113 | N-glycan processing (GO:0006491) | 2.72455923 |
| 114 | fucosylation (GO:0036065) | 2.71963545 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71948313 |
| 116 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 2.71049756 |
| 117 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.70865537 |
| 118 | modulation by symbiont of host immune response (GO:0052553) | 2.70865537 |
| 119 | positive regulation by symbiont of host defense response (GO:0052509) | 2.70865537 |
| 120 | modulation by symbiont of host defense response (GO:0052031) | 2.70865537 |
| 121 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.70865537 |
| 122 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.70865537 |
| 123 | response to interferon-gamma (GO:0034341) | 2.69568971 |
| 124 | positive thymic T cell selection (GO:0045059) | 2.68480193 |
| 125 | positive regulation of B cell activation (GO:0050871) | 2.65941932 |
| 126 | regulation of water loss via skin (GO:0033561) | 2.65287708 |
| 127 | chronic inflammatory response (GO:0002544) | 2.64117994 |
| 128 | wound healing, spreading of epidermal cells (GO:0035313) | 2.64049457 |
| 129 | regulation of superoxide anion generation (GO:0032928) | 2.63974206 |
| 130 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.63052732 |
| 131 | cellular extravasation (GO:0045123) | 2.62215883 |
| 132 | tissue homeostasis (GO:0001894) | 2.62145131 |
| 133 | response to unfolded protein (GO:0006986) | 2.59220590 |
| 134 | T-helper 1 type immune response (GO:0042088) | 2.58427711 |
| 135 | establishment of skin barrier (GO:0061436) | 2.56215804 |
| 136 | regulation of integrin activation (GO:0033623) | 2.55415923 |
| 137 | regulation of T cell tolerance induction (GO:0002664) | 2.55295487 |
| 138 | macrophage activation involved in immune response (GO:0002281) | 2.55231284 |
| 139 | interferon-gamma secretion (GO:0072643) | 2.55170798 |
| 140 | positive regulation of histone deacetylation (GO:0031065) | 2.54747379 |
| 141 | ER overload response (GO:0006983) | 2.51208567 |
| 142 | negative regulation of humoral immune response (GO:0002921) | 2.51124446 |
| 143 | regulation of B cell apoptotic process (GO:0002902) | 2.50948070 |
| 144 | negative T cell selection (GO:0043383) | 2.49944505 |
| 145 | L-serine transport (GO:0015825) | 2.48817856 |
| 146 | negative regulation of complement activation (GO:0045916) | 2.47193155 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44294075 |
| 148 | myeloid dendritic cell differentiation (GO:0043011) | 2.43620975 |
| 149 | establishment of planar polarity (GO:0001736) | 2.42054437 |
| 150 | establishment of tissue polarity (GO:0007164) | 2.42054437 |
| 151 | negative regulation of interleukin-12 production (GO:0032695) | 2.41657811 |
| 152 | defense response to protozoan (GO:0042832) | 2.41454743 |
| 153 | positive regulation of type 2 immune response (GO:0002830) | 2.40687230 |
| 154 | regulation of regulatory T cell differentiation (GO:0045589) | 2.40495583 |
| 155 | detection of biotic stimulus (GO:0009595) | 2.39626538 |
| 156 | response to interleukin-15 (GO:0070672) | 2.39320034 |
| 157 | regulation of necroptotic process (GO:0060544) | 2.38637553 |
| 158 | dendritic cell chemotaxis (GO:0002407) | 2.38197342 |
| 159 | cellular glucuronidation (GO:0052695) | 2.34741290 |
| 160 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.34235872 |
| 161 | detection of molecule of bacterial origin (GO:0032490) | 2.34091007 |
| 162 | regulation of necrotic cell death (GO:0010939) | 2.31861229 |
| 163 | regulation of macrophage chemotaxis (GO:0010758) | 2.31772025 |
| 164 | NIK/NF-kappaB signaling (GO:0038061) | 2.30570867 |
| 165 | daunorubicin metabolic process (GO:0044597) | 2.29968352 |
| 166 | polyketide metabolic process (GO:0030638) | 2.29968352 |
| 167 | doxorubicin metabolic process (GO:0044598) | 2.29968352 |
| 168 | adhesion of symbiont to host cell (GO:0044650) | 2.29927394 |
| 169 | virion attachment to host cell (GO:0019062) | 2.29927394 |
| 170 | chemical homeostasis within a tissue (GO:0048875) | 2.29462331 |
| 171 | protein-chromophore linkage (GO:0018298) | 2.28086666 |
| 172 | complement activation (GO:0006956) | 15.8642901 |
| 173 | protein activation cascade (GO:0072376) | 10.2551394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.50066061 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.70848297 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.21087889 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.98916171 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.50853304 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 4.32458673 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.24323866 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.93028242 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.76151724 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.69843665 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.57453522 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.45012441 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.31841949 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.08026358 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.07973983 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85768913 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.76761941 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.70676078 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67868448 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54882150 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.46643262 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.42017367 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30801940 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27937490 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27793054 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.25471606 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23392976 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20558392 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16565566 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14739145 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.12654420 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.09950918 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09548896 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04672557 |
| 35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04398770 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.04051549 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03154631 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.00946804 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90285925 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84962807 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.79910734 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78955989 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77225500 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76541606 |
| 45 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.75181276 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.66263857 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62779175 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61633247 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61444286 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59944143 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.57974409 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.57248223 |
| 53 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.52717039 |
| 54 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50913061 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50515958 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50105183 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.49908946 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.48225737 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.47069012 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44236992 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40904344 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37130409 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.36245661 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33869411 |
| 65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30522209 |
| 66 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29652841 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26348321 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23599857 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22897278 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22486619 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21175580 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20850045 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18638508 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18310243 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17441211 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.15926344 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14920219 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14661786 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12104919 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10960940 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10673246 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07626657 |
| 83 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07424866 |
| 84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07241867 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06271339 |
| 86 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.06206762 |
| 87 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.05588817 |
| 88 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.05588817 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05144585 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03031768 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02510270 |
| 92 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.02484703 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01182737 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00459682 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00065127 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99106751 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95978017 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.95445718 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94319117 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94206338 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91531028 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91233380 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90426786 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88612494 |
| 105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88338319 |
| 106 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88285431 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87325138 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.86863975 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86620443 |
| 110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86185387 |
| 111 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86140064 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85682420 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85682420 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85612173 |
| 115 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.85010307 |
| 116 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84260679 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83731165 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83541757 |
| 119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83496184 |
| 120 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82559740 |
| 121 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82413232 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82202570 |
| 123 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.81610447 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81345135 |
| 125 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78692243 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78049216 |
| 127 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76979930 |
| 128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76874056 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76162531 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75513222 |
| 131 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74384929 |
| 132 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73866999 |
| 133 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73832721 |
| 134 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73784794 |
| 135 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73398853 |
| 136 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72779557 |
| 137 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.72351157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.75539504 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.08691591 |
| 3 | MP0003724_increased_susceptibility_to | 5.00744783 |
| 4 | MP0001800_abnormal_humoral_immune | 4.60366328 |
| 5 | MP0001790_abnormal_immune_system | 3.70369323 |
| 6 | MP0005387_immune_system_phenotype | 3.70369323 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.44665981 |
| 8 | MP0005275_abnormal_skin_tensile | 3.22396657 |
| 9 | MP0005671_abnormal_response_to | 3.00817400 |
| 10 | MP0002723_abnormal_immune_serum | 2.85030456 |
| 11 | MP0003436_decreased_susceptibility_to | 2.79605972 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.78414373 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.76498525 |
| 14 | MP0001819_abnormal_immune_cell | 2.72965833 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.59767323 |
| 16 | MP0002398_abnormal_bone_marrow | 2.57281730 |
| 17 | MP0000716_abnormal_immune_system | 2.53357664 |
| 18 | MP0000685_abnormal_immune_system | 2.49147335 |
| 19 | MP0001879_abnormal_lymphatic_vessel | 2.38935648 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.31652070 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.23599435 |
| 22 | MP0005025_abnormal_response_to | 2.22300129 |
| 23 | MP0000689_abnormal_spleen_morphology | 2.19604937 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 2.14819752 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 2.13652298 |
| 26 | MP0002429_abnormal_blood_cell | 2.05623504 |
| 27 | MP0002419_abnormal_innate_immunity | 2.03543832 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.02896659 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.02576799 |
| 30 | MP0000579_abnormal_nail_morphology | 1.97459108 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.85449197 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.78168827 |
| 33 | MP0002722_abnormal_immune_system | 1.77901536 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.76248260 |
| 35 | MP0004947_skin_inflammation | 1.67143370 |
| 36 | MP0005166_decreased_susceptibility_to | 1.66698711 |
| 37 | MP0003448_altered_tumor_morphology | 1.60254944 |
| 38 | MP0009785_altered_susceptibility_to | 1.58505562 |
| 39 | MP0002006_tumorigenesis | 1.55249046 |
| 40 | MP0000858_altered_metastatic_potential | 1.54526084 |
| 41 | MP0006054_spinal_hemorrhage | 1.52614563 |
| 42 | MP0003279_aneurysm | 1.51748525 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 1.50005919 |
| 44 | MP0001873_stomach_inflammation | 1.47607342 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.46333664 |
| 46 | MP0004510_myositis | 1.45125436 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.44261169 |
| 48 | MP0003828_pulmonary_edema | 1.44100466 |
| 49 | MP0002405_respiratory_system_inflammati | 1.42736020 |
| 50 | MP0000383_abnormal_hair_follicle | 1.41532970 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.39674375 |
| 52 | MP0001851_eye_inflammation | 1.39294377 |
| 53 | MP0000343_altered_response_to | 1.38162750 |
| 54 | MP0001853_heart_inflammation | 1.35269163 |
| 55 | MP0003045_fibrosis | 1.34022347 |
| 56 | MP0002933_joint_inflammation | 1.33393859 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.31661936 |
| 58 | MP0005164_abnormal_response_to | 1.31020055 |
| 59 | MP0008004_abnormal_stomach_pH | 1.29862089 |
| 60 | MP0005390_skeleton_phenotype | 1.29249979 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.24973763 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.24968151 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.20368297 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.19956830 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.18097604 |
| 66 | MP0008872_abnormal_physiological_respon | 1.17719935 |
| 67 | MP0005310_abnormal_salivary_gland | 1.16288415 |
| 68 | MP0001533_abnormal_skeleton_physiology | 1.15233125 |
| 69 | MP0008569_lethality_at_weaning | 1.12753091 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.12170075 |
| 71 | MP0008260_abnormal_autophagy | 1.11320383 |
| 72 | MP0005360_urolithiasis | 1.10500567 |
| 73 | MP0000920_abnormal_myelination | 1.09631268 |
| 74 | MP0003866_abnormal_defecation | 1.08705749 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.08541523 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.06630455 |
| 77 | MP0002019_abnormal_tumor_incidence | 1.05812768 |
| 78 | MP0005257_abnormal_intraocular_pressure | 1.02023899 |
| 79 | MP0001663_abnormal_digestive_system | 1.01727589 |
| 80 | MP0002254_reproductive_system_inflammat | 1.00726525 |
| 81 | MP0006082_CNS_inflammation | 1.00186590 |
| 82 | MP0003075_altered_response_to | 0.99998949 |
| 83 | MP0009764_decreased_sensitivity_to | 0.99322855 |
| 84 | MP0005076_abnormal_cell_differentiation | 0.99032160 |
| 85 | MP0009046_muscle_twitch | 0.98879198 |
| 86 | MP0001958_emphysema | 0.98591518 |
| 87 | MP0010368_abnormal_lymphatic_system | 0.98076788 |
| 88 | MP0002139_abnormal_hepatobiliary_system | 0.97922847 |
| 89 | MP0004858_abnormal_nervous_system | 0.96847520 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.95750261 |
| 91 | MP0000249_abnormal_blood_vessel | 0.93014510 |
| 92 | MP0004883_abnormal_blood_vessel | 0.92539433 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.91572833 |
| 94 | MP0002796_impaired_skin_barrier | 0.90933804 |
| 95 | MP0000490_abnormal_crypts_of | 0.89964326 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.88312108 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.87415652 |
| 98 | MP0009278_abnormal_bone_marrow | 0.86598381 |
| 99 | MP0008469_abnormal_protein_level | 0.86299517 |
| 100 | MP0002168_other_aberrant_phenotype | 0.86209478 |
| 101 | MP0000604_amyloidosis | 0.85833892 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.85459631 |
| 103 | MP0002060_abnormal_skin_morphology | 0.85220419 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.83307989 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.83215567 |
| 106 | MP0003795_abnormal_bone_structure | 0.81535649 |
| 107 | MP0001919_abnormal_reproductive_system | 0.80627729 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.80319241 |
| 109 | MP0009840_abnormal_foam_cell | 0.80305778 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.79670386 |
| 111 | MP0000733_abnormal_muscle_development | 0.79481416 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.77691255 |
| 113 | MP0000609_abnormal_liver_physiology | 0.76793988 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.74329590 |
| 115 | MP0001666_abnormal_nutrient_absorption | 0.74025601 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.73597797 |
| 117 | MP0000678_abnormal_parathyroid_gland | 0.71941222 |
| 118 | MP0003091_abnormal_cell_migration | 0.71096384 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.70626263 |
| 120 | MP0005058_abnormal_lysosome_morphology | 0.70501095 |
| 121 | MP0002133_abnormal_respiratory_system | 0.69284573 |
| 122 | MP0005388_respiratory_system_phenotype | 0.69284573 |
| 123 | MP0008874_decreased_physiological_sensi | 0.67412058 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.66449474 |
| 125 | MP0005397_hematopoietic_system_phenotyp | 0.64773931 |
| 126 | MP0001545_abnormal_hematopoietic_system | 0.64773931 |
| 127 | MP0001881_abnormal_mammary_gland | 0.62594860 |
| 128 | MP0002083_premature_death | 0.61346999 |
| 129 | MP0008873_increased_physiological_sensi | 0.61342889 |
| 130 | MP0001191_abnormal_skin_condition | 0.61316670 |
| 131 | MP0005381_digestive/alimentary_phenotyp | 0.61179189 |
| 132 | MP0004134_abnormal_chest_morphology | 0.59813598 |
| 133 | MP0005023_abnormal_wound_healing | 0.59567999 |
| 134 | MP0003186_abnormal_redox_activity | 0.59503418 |
| 135 | MP0000477_abnormal_intestine_morphology | 0.59251236 |
| 136 | MP0003690_abnormal_glial_cell | 0.59007830 |
| 137 | MP0003191_abnormal_cellular_cholesterol | 0.58790949 |
| 138 | MP0004859_abnormal_synaptic_plasticity | 0.58428790 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.54742718 |
| 140 | MP0009763_increased_sensitivity_to | 0.54582436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.21724175 |
| 2 | Abnormality of B cell number (HP:0010975) | 8.96590532 |
| 3 | B lymphocytopenia (HP:0010976) | 8.96590532 |
| 4 | Prostate neoplasm (HP:0100787) | 8.80459776 |
| 5 | Colitis (HP:0002583) | 7.52911992 |
| 6 | Recurrent sinusitis (HP:0011108) | 6.98867519 |
| 7 | Cellulitis (HP:0100658) | 6.73670816 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 6.26683451 |
| 9 | Recurrent bronchitis (HP:0002837) | 6.16699351 |
| 10 | Verrucae (HP:0200043) | 5.94775814 |
| 11 | Papilloma (HP:0012740) | 5.94775814 |
| 12 | Recurrent viral infections (HP:0004429) | 5.79809395 |
| 13 | Inflammation of the large intestine (HP:0002037) | 5.70223176 |
| 14 | Abnormality of the prostate (HP:0008775) | 5.60675589 |
| 15 | Gastrointestinal inflammation (HP:0004386) | 5.49478377 |
| 16 | IgM deficiency (HP:0002850) | 5.41091711 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 5.25227644 |
| 18 | Meningitis (HP:0001287) | 4.91459021 |
| 19 | Recurrent pneumonia (HP:0006532) | 4.77266423 |
| 20 | Chronic otitis media (HP:0000389) | 4.37274311 |
| 21 | Abnormality of complement system (HP:0005339) | 4.12631527 |
| 22 | Alopecia of scalp (HP:0002293) | 4.06350067 |
| 23 | Osteomyelitis (HP:0002754) | 4.05437126 |
| 24 | Complement deficiency (HP:0004431) | 3.86946563 |
| 25 | Recurrent lower respiratory tract infections (HP:0002783) | 3.84172874 |
| 26 | Glomerulonephritis (HP:0000099) | 3.83139194 |
| 27 | Chronic sinusitis (HP:0011109) | 3.76294885 |
| 28 | Thick nail (HP:0001805) | 3.74055277 |
| 29 | Emphysema (HP:0002097) | 3.68678680 |
| 30 | Recurrent otitis media (HP:0000403) | 3.68430375 |
| 31 | Leukocytosis (HP:0001974) | 3.66401618 |
| 32 | Bronchitis (HP:0012387) | 3.46186754 |
| 33 | Abnormal hair laboratory examination (HP:0003328) | 3.45318478 |
| 34 | Sepsis (HP:0100806) | 3.41540957 |
| 35 | Abnormality of male internal genitalia (HP:0000022) | 3.32530108 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 3.30818998 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.16306331 |
| 38 | Thyroiditis (HP:0100646) | 3.11888167 |
| 39 | Skin rash (HP:0000988) | 3.07607832 |
| 40 | IgA deficiency (HP:0002720) | 3.06134180 |
| 41 | Restrictive lung disease (HP:0002091) | 3.05529587 |
| 42 | Vasculitis (HP:0002633) | 3.04639546 |
| 43 | Xerostomia (HP:0000217) | 3.02425108 |
| 44 | Nephritis (HP:0000123) | 3.00221770 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.99432105 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.91231660 |
| 47 | Pili torti (HP:0003777) | 2.90280816 |
| 48 | Follicular hyperkeratosis (HP:0007502) | 2.89942344 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.86069436 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.85181833 |
| 51 | Lymphopenia (HP:0001888) | 2.82862509 |
| 52 | Orchitis (HP:0100796) | 2.82178893 |
| 53 | Neoplasm of the lung (HP:0100526) | 2.79198467 |
| 54 | Small epiphyses (HP:0010585) | 2.78471923 |
| 55 | IgG deficiency (HP:0004315) | 2.77751456 |
| 56 | Abnormality of secondary sexual hair (HP:0009888) | 2.75349004 |
| 57 | Abnormality of the axillary hair (HP:0100134) | 2.75349004 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.75157702 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.68412566 |
| 60 | Malnutrition (HP:0004395) | 2.67896281 |
| 61 | Eczematoid dermatitis (HP:0000976) | 2.61269427 |
| 62 | Nasal polyposis (HP:0100582) | 2.56428482 |
| 63 | Gastrointestinal infarctions (HP:0005244) | 2.51033189 |
| 64 | Premature loss of primary teeth (HP:0006323) | 2.50104559 |
| 65 | Recurrent skin infections (HP:0001581) | 2.49506803 |
| 66 | Metaphyseal cupping (HP:0003021) | 2.47359335 |
| 67 | Increased IgE level (HP:0003212) | 2.47076506 |
| 68 | Abnormality of T cells (HP:0002843) | 2.46023262 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39837590 |
| 70 | Neoplasm of the respiratory system (HP:0100606) | 2.39373286 |
| 71 | Hypermelanotic macule (HP:0001034) | 2.39330911 |
| 72 | Skin ulcer (HP:0200042) | 2.31859351 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.29992557 |
| 74 | Mitral stenosis (HP:0001718) | 2.27571969 |
| 75 | Bronchiectasis (HP:0002110) | 2.23983362 |
| 76 | Hemoptysis (HP:0002105) | 2.19822929 |
| 77 | Peritonitis (HP:0002586) | 2.19767254 |
| 78 | Optic neuritis (HP:0100653) | 2.16864173 |
| 79 | Retrobulbar optic neuritis (HP:0100654) | 2.16864173 |
| 80 | Neutropenia (HP:0001875) | 2.16075690 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14455684 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14455684 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.14270920 |
| 84 | Vacuolated lymphocytes (HP:0001922) | 2.13847308 |
| 85 | Hypoplastic labia majora (HP:0000059) | 2.10160690 |
| 86 | Abnormality of the salivary glands (HP:0010286) | 2.07758336 |
| 87 | T lymphocytopenia (HP:0005403) | 2.07745719 |
| 88 | Abnormality of T cell number (HP:0011839) | 2.06963646 |
| 89 | Abnormality of the peritoneum (HP:0002585) | 2.05893193 |
| 90 | Atrophic scars (HP:0001075) | 2.04451846 |
| 91 | Pulmonary infiltrates (HP:0002113) | 2.02826038 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 2.01052435 |
| 93 | Depressed nasal tip (HP:0000437) | 1.99852878 |
| 94 | Blepharitis (HP:0000498) | 1.99787248 |
| 95 | Obstructive lung disease (HP:0006536) | 1.99273988 |
| 96 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99273988 |
| 97 | Purpura (HP:0000979) | 1.95817359 |
| 98 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94919953 |
| 99 | Cerebral aneurysm (HP:0004944) | 1.94132362 |
| 100 | Ankyloglossia (HP:0010296) | 1.93946074 |
| 101 | Breast hypoplasia (HP:0003187) | 1.93633426 |
| 102 | Abnormal foot bone ossification (HP:0010675) | 1.92644645 |
| 103 | Selective tooth agenesis (HP:0001592) | 1.92285291 |
| 104 | Fragile skin (HP:0001030) | 1.91665743 |
| 105 | Hematochezia (HP:0002573) | 1.91466080 |
| 106 | Abnormality of the labia majora (HP:0012881) | 1.88584877 |
| 107 | Bladder diverticulum (HP:0000015) | 1.88074965 |
| 108 | Keratoconjunctivitis sicca (HP:0001097) | 1.87607502 |
| 109 | Osteolytic defects of the hand bones (HP:0009699) | 1.86659378 |
| 110 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86659378 |
| 111 | Chronic diarrhea (HP:0002028) | 1.86042532 |
| 112 | Split foot (HP:0001839) | 1.85766027 |
| 113 | Erythema (HP:0010783) | 1.82959567 |
| 114 | Abnormality of nail color (HP:0100643) | 1.82955742 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 1.82653682 |
| 116 | Oligodontia (HP:0000677) | 1.80211003 |
| 117 | Flattened epiphyses (HP:0003071) | 1.79492547 |
| 118 | Viral hepatitis (HP:0006562) | 1.77803801 |
| 119 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.75530265 |
| 120 | Absent eyelashes (HP:0000561) | 1.74955051 |
| 121 | Leukopenia (HP:0001882) | 1.72208788 |
| 122 | Pustule (HP:0200039) | 1.72052234 |
| 123 | Myositis (HP:0100614) | 1.70373758 |
| 124 | Arthralgia (HP:0002829) | 1.70330214 |
| 125 | Macroorchidism (HP:0000053) | 1.69564544 |
| 126 | Abnormality of the fingertips (HP:0001211) | 1.67880840 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 1.66605746 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.65243734 |
| 129 | Lymphoma (HP:0002665) | 1.65121462 |
| 130 | Basal cell carcinoma (HP:0002671) | 1.64601048 |
| 131 | Urticaria (HP:0001025) | 1.64445349 |
| 132 | Hypoplasia of the thymus (HP:0000778) | 1.62875524 |
| 133 | Ulnar deviation of the wrist (HP:0003049) | 1.62856730 |
| 134 | Dehydration (HP:0001944) | 1.59313404 |
| 135 | Abnormality of the intrinsic pathway (HP:0010989) | 1.58959669 |
| 136 | Cervical subluxation (HP:0003308) | 1.58789022 |
| 137 | Thrombocytosis (HP:0001894) | 1.56184570 |
| 138 | Papilledema (HP:0001085) | 1.54020672 |
| 139 | Acrocyanosis (HP:0001063) | 1.53933810 |
| 140 | Combined immunodeficiency (HP:0005387) | 1.52499129 |
| 141 | Chest pain (HP:0100749) | 1.51605278 |
| 142 | Abnormality of the lumbar spine (HP:0100712) | 1.50914327 |
| 143 | Eosinophilia (HP:0001880) | 1.50119486 |
| 144 | Encephalitis (HP:0002383) | 1.49105811 |
| 145 | Autoimmune thrombocytopenia (HP:0001973) | 1.48381685 |
| 146 | Hypergammaglobulinemia (HP:0010702) | 1.47851025 |
| 147 | Deep venous thrombosis (HP:0002625) | 1.46065945 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.44980756 |
| 149 | Mucopolysacchariduria (HP:0008155) | 1.44123746 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.44123746 |
| 151 | Gingival bleeding (HP:0000225) | 1.41788250 |
| 152 | Gingivitis (HP:0000230) | 1.41510262 |
| 153 | Coxa valga (HP:0002673) | 1.40717483 |
| 154 | Irregular vertebral endplates (HP:0003301) | 1.40412582 |
| 155 | Myocardial infarction (HP:0001658) | 1.40181270 |
| 156 | Severe combined immunodeficiency (HP:0004430) | 1.39928749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 7.26872583 |
| 2 | MAP4K1 | 5.21623809 |
| 3 | TAOK3 | 3.90395331 |
| 4 | PRPF4B | 3.23006201 |
| 5 | RIPK4 | 3.20687805 |
| 6 | GRK6 | 3.18854961 |
| 7 | TYK2 | 2.85348412 |
| 8 | MAP3K10 | 2.83270759 |
| 9 | TGFBR1 | 2.78964275 |
| 10 | SIK2 | 2.49572365 |
| 11 | EIF2AK3 | 2.42746214 |
| 12 | SYK | 2.31955018 |
| 13 | NME2 | 2.23278422 |
| 14 | BLK | 2.10896830 |
| 15 | MAP3K14 | 1.99666341 |
| 16 | CSF1R | 1.98470600 |
| 17 | CDC42BPA | 1.98244055 |
| 18 | KIT | 1.92367088 |
| 19 | RIPK1 | 1.78095523 |
| 20 | JAK1 | 1.77847270 |
| 21 | TXK | 1.72531273 |
| 22 | BTK | 1.70108669 |
| 23 | IRAK3 | 1.64167763 |
| 24 | IRAK4 | 1.60364905 |
| 25 | MAP3K13 | 1.55478636 |
| 26 | MAP3K1 | 1.36027069 |
| 27 | MAP3K3 | 1.29763782 |
| 28 | HIPK2 | 1.28265565 |
| 29 | HCK | 1.28219915 |
| 30 | PRKCH | 1.27907238 |
| 31 | PDGFRA | 1.27121317 |
| 32 | STK24 | 1.23666557 |
| 33 | IRAK1 | 1.23646799 |
| 34 | ITK | 1.19824199 |
| 35 | STK10 | 1.16893472 |
| 36 | PIK3CG | 1.16278822 |
| 37 | LYN | 1.14857593 |
| 38 | TBK1 | 1.13122521 |
| 39 | LATS1 | 1.11338899 |
| 40 | FGFR4 | 1.11001072 |
| 41 | FES | 1.05591322 |
| 42 | MAP3K9 | 1.02321090 |
| 43 | IKBKE | 1.01818596 |
| 44 | JAK3 | 1.00010351 |
| 45 | MST1R | 0.99112648 |
| 46 | BMPR2 | 0.98058115 |
| 47 | LRRK2 | 0.97086780 |
| 48 | EPHB1 | 0.96307715 |
| 49 | FGFR3 | 0.95213921 |
| 50 | YES1 | 0.93594078 |
| 51 | DMPK | 0.91143636 |
| 52 | FER | 0.89411214 |
| 53 | PIM1 | 0.88614483 |
| 54 | ALK | 0.88494397 |
| 55 | KSR2 | 0.88453072 |
| 56 | TEC | 0.87521443 |
| 57 | NEK9 | 0.86853951 |
| 58 | NEK2 | 0.86677096 |
| 59 | TGFBR2 | 0.83268220 |
| 60 | PRKCQ | 0.83134338 |
| 61 | CSK | 0.77800026 |
| 62 | CDK12 | 0.75822016 |
| 63 | SIK1 | 0.75346371 |
| 64 | RET | 0.73863982 |
| 65 | IKBKB | 0.73831879 |
| 66 | STK38L | 0.73121893 |
| 67 | PDK1 | 0.72577387 |
| 68 | NLK | 0.72077286 |
| 69 | MAP3K6 | 0.71525240 |
| 70 | LCK | 0.71050813 |
| 71 | BMX | 0.70410598 |
| 72 | EEF2K | 0.70389228 |
| 73 | TRIB3 | 0.69297010 |
| 74 | MAPK7 | 0.67813971 |
| 75 | CLK1 | 0.66192911 |
| 76 | LATS2 | 0.65549630 |
| 77 | MAP3K2 | 0.64036252 |
| 78 | BCKDK | 0.62743498 |
| 79 | PKN2 | 0.61311649 |
| 80 | JAK2 | 0.58193420 |
| 81 | DDR2 | 0.56504954 |
| 82 | PAK4 | 0.55721421 |
| 83 | PDK2 | 0.53508884 |
| 84 | FYN | 0.53477096 |
| 85 | PRKD1 | 0.52100027 |
| 86 | PDGFRB | 0.49166761 |
| 87 | SMG1 | 0.49027787 |
| 88 | TAOK1 | 0.48035967 |
| 89 | TAOK2 | 0.48015781 |
| 90 | MAPK4 | 0.47832411 |
| 91 | MST4 | 0.45323770 |
| 92 | MAPKAPK2 | 0.45051229 |
| 93 | MAP3K7 | 0.44997942 |
| 94 | IRAK2 | 0.44142749 |
| 95 | UHMK1 | 0.42412995 |
| 96 | PKN1 | 0.41822176 |
| 97 | FGR | 0.39873277 |
| 98 | MYLK | 0.39849990 |
| 99 | MAPK12 | 0.38582613 |
| 100 | SGK3 | 0.36916862 |
| 101 | PRKD2 | 0.36770370 |
| 102 | BRSK1 | 0.36269466 |
| 103 | PRKCD | 0.36232773 |
| 104 | MAPK11 | 0.35123666 |
| 105 | PTK6 | 0.35080058 |
| 106 | GRK5 | 0.34457373 |
| 107 | PRKG2 | 0.33870465 |
| 108 | ABL1 | 0.33546613 |
| 109 | PDPK1 | 0.33384556 |
| 110 | TTN | 0.33291196 |
| 111 | PIK3CA | 0.31645861 |
| 112 | CDK4 | 0.30483768 |
| 113 | MARK3 | 0.28540998 |
| 114 | INSR | 0.28220278 |
| 115 | PTK2B | 0.27971178 |
| 116 | CHUK | 0.27357904 |
| 117 | EGFR | 0.27299549 |
| 118 | CDK6 | 0.27001516 |
| 119 | BUB1 | 0.26985614 |
| 120 | FRK | 0.26666676 |
| 121 | BRD4 | 0.26449410 |
| 122 | CSNK1G2 | 0.25970658 |
| 123 | EPHA3 | 0.24818403 |
| 124 | IGF1R | 0.24807179 |
| 125 | MAP2K3 | 0.24278413 |
| 126 | MATK | 0.24214085 |
| 127 | TESK1 | 0.24104003 |
| 128 | BRSK2 | 0.23142991 |
| 129 | CSNK1A1L | 0.22157337 |
| 130 | STK11 | 0.20917443 |
| 131 | MAP3K8 | 0.18810335 |
| 132 | RAF1 | 0.17504570 |
| 133 | WNK1 | 0.16728761 |
| 134 | CSNK1G3 | 0.16473026 |
| 135 | MAPK3 | 0.13858263 |
| 136 | ZAP70 | 0.13747763 |
| 137 | SIK3 | 0.13435125 |
| 138 | SRC | 0.13096836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 7.90193047 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.03878669 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.40294978 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.34301723 |
| 5 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 3.21897271 |
| 6 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.20614024 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.87303289 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.35983087 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30774516 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.06405357 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87371337 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.81894745 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78259710 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66258855 |
| 15 | Asthma_Homo sapiens_hsa05310 | 1.65549764 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62598883 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.60225165 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47871811 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41865381 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.41543744 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.39282648 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.35270136 |
| 23 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.34264866 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31668844 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29639888 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27216979 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.25128235 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13203175 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13075179 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10668883 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.09477552 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09124134 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04616189 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03370482 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02872473 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97178995 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93951880 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93643621 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92283202 |
| 40 | Measles_Homo sapiens_hsa05162 | 0.91802832 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89922824 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89439536 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 0.83626806 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.81055245 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.79721008 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.79549977 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74540723 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.73389927 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.72793105 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72266212 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70997873 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70157486 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.70152517 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67691735 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67665225 |
| 56 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64287710 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.64115064 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63199164 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.63146690 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62800372 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61146459 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.60888916 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60721562 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60175760 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59881098 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58480298 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58022146 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57949400 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57103336 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56936095 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56396724 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55628860 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55000582 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54129684 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53020100 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51891016 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.50510340 |
| 78 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49710656 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.49188951 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48486835 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.48297567 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.48195532 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47633830 |
| 84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47413535 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47094963 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46912800 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.46460673 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45715273 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.45507530 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45373724 |
| 91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44355999 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43359434 |
| 93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43110256 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42473601 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42334862 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.42294424 |
| 97 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41819445 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41738973 |
| 99 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40723308 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39462456 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39047386 |
| 102 | Bladder cancer_Homo sapiens_hsa05219 | 0.38705851 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38572143 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38224184 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38131112 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37781700 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36971074 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.36969200 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.36868647 |
| 110 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36741440 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.36371754 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35408199 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34691969 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34093273 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33725736 |
| 116 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33535923 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.32322001 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32105606 |
| 119 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31938990 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31312771 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.30323895 |
| 122 | Insulin secretion_Homo sapiens_hsa04911 | 0.29328639 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.28827127 |
| 124 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28672464 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.27648419 |
| 126 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27603548 |
| 127 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25280433 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.25043692 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23377676 |
| 130 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.22729969 |
| 131 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22564333 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22172492 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.21576561 |
| 134 | Histidine metabolism_Homo sapiens_hsa00340 | 0.21089442 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20341452 |
| 136 | Lysosome_Homo sapiens_hsa04142 | 0.19830421 |
| 137 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.19568277 |

